– USA, WI – SHINE Technologies, LLC, a next-generation fusion technology company, today announced the appointment of Dr. Frederick Robertson (MD) to its board of directors, effective immediately.
About Dr. Frederick Robertson
Dr. Frederick Robertson brings a wealth of experience in building companies in the medical device, life science, and pharmaceutical industries. He was CEO and director of TomoTherapy, a producer of sophisticated X-ray-based cancer therapy equipment until the company was acquired in 2011. Before that, Robertson’s roles included: President and CEO of GE Marquette Medical Systems; CCO of GE Medical Systems; and President and CEO, among other management positions, of Marquette Medical Systems.
Along with serving as an advisor to SHINE, Robertson has been a venture partner at Baird Capital since 2011 and retired from the anesthesiology faculty at the University of Wisconsin School of Medicine and Public Health in 2018. He serves on the board of directors of the University of Wisconsin Foundation, the Morgridge Institute for Research, Ensodata, Inc., Elucent, Inc., Saranas Inc., Virtual Incision, and Zurex Pharma, Inc.; and previously served as a board member for Lantheus.
Robertson earned his MBA from San Diego State University and an M.D. from the University of Wisconsin Medical School.
“This is an exciting time for SHINE as it works to make fusion-driven medical isotopes a reality,” said Dr. Robertson. “There is an urgent, worldwide need for these critical diagnostic and therapeutic nuclear isotopes, especially lutetium-177, and I’m eager to play a role in combating those shortages.”
About SHINE Technologies
Based in Janesville, Wisconsin, SHINE deploys its safe, cost-effective, and environmentally friendly fusion technology in a stepwise approach. Its systems are used to inspect industrial components in the aerospace, defense, energy, and other sectors. SHINE’s proprietary medical isotope production processes create non-carrier-added lutetium-177 and are expected to create molybdenum-99. In the future, SHINE plans to scale its fusion technology to help solve one of the energy’s most challenging hurdles by recycling nuclear waste. Through a purpose-driven and phased approach, SHINE aims to generate fusion power to deliver clean, abundant energy that could transform life on Earth.
Source: https://www.shinefusion.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.